Andy
Retired committee member
Since the coronavirus disease 2019 (COVID-19) outbreak has become a pandemic, medical staff and researchers have devotedly managed the disease in terms of pathogens, prevention, and treatment. Even so, the virus continues to wreak havoc in people's lives. Recent evidence shows that patients with severe acute respiratory syndrome coronavirus 2 show distinct symptoms ranging from asymptomatic or mild infection to fatal disease. Moreover, this virus not only provokes an acute inflammatory response but could also cause a range of persistent symptoms after the phase of acute infection. The National Institute for Health and Care Excellence defines this phenomenon as long COVID.1 Currently, there is no definite definition of long COVID. However, the basic argument, that patients who have recovered from acute infection present with persistent symptoms that cannot be explained by another diagnosis beyond 3–4 weeks postinfection, remains the same. Academic publications have estimated that 10%–20% of patients with COVID-19 have some complaints after COVID-19.2
Most patients with COVID-19 present with respiratory dysfunction, fatigue, and psychological disorders during and after acute infection, and their lives are greatly affected. Under this circumstance, pulmonary rehabilitation (PR) has become a powerful weapon to deal with those symptoms in the context of quantities of evidence of its efficiency.3 However, restricting quarantine to minimize viral spread may limit the utility of conventional PR programs. Thus, new techniques and innovative programs or approaches must be discussed and estimated. In this case, we could obtain a more comprehensive and critical perspective on the frontiers of medicine.
Open access, https://onlinelibrary.wiley.com/doi/10.1002/cdt3.42
Most patients with COVID-19 present with respiratory dysfunction, fatigue, and psychological disorders during and after acute infection, and their lives are greatly affected. Under this circumstance, pulmonary rehabilitation (PR) has become a powerful weapon to deal with those symptoms in the context of quantities of evidence of its efficiency.3 However, restricting quarantine to minimize viral spread may limit the utility of conventional PR programs. Thus, new techniques and innovative programs or approaches must be discussed and estimated. In this case, we could obtain a more comprehensive and critical perspective on the frontiers of medicine.
Open access, https://onlinelibrary.wiley.com/doi/10.1002/cdt3.42
